Trial of Cannabidiol for Drug-Resistant Seizures in the Dravet Syndrome

Seizures are difficult to control in the Dravet syndrome, a rare genetic form of epileptic encephalopathy primarily due to loss-of-function mutations in the SCN1A gene. Interest in cannabidiol for the treatment of epilepsy was generated by media reports of efficacy in children with the Dravet…

http://ift.tt/2rXKIhR